Thalys Medical Technology Group Inc
SSE:603716
Thalys Medical Technology Group Inc
Operating Income
Thalys Medical Technology Group Inc
Operating Income Peer Comparison
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Thalys Medical Technology Group Inc
SSE:603716
|
Operating Income
-¥83.7m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Beigene Ltd
HKEX:6160
|
Operating Income
-¥12B
|
CAGR 3-Years
-21%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Innovent Biologics Inc
HKEX:1801
|
Operating Income
-¥1.1B
|
CAGR 3-Years
-36%
|
CAGR 5-Years
6%
|
CAGR 10-Years
N/A
|
|
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
|
Operating Income
¥1.4B
|
CAGR 3-Years
22%
|
CAGR 5-Years
55%
|
CAGR 10-Years
N/A
|
|
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
|
Operating Income
¥9.9B
|
CAGR 3-Years
38%
|
CAGR 5-Years
46%
|
CAGR 10-Years
47%
|
|
Imeik Technology Development Co Ltd
SZSE:300896
|
Operating Income
¥1.4B
|
CAGR 3-Years
59%
|
CAGR 5-Years
72%
|
CAGR 10-Years
N/A
|
See Also
What is Thalys Medical Technology Group Inc's Operating Income?
Operating Income
-83.7m
CNY
Based on the financial report for Sep 30, 2023, Thalys Medical Technology Group Inc's Operating Income amounts to -83.7m CNY.